Next Generation Sequencing Market to become a breeding ground for investors in coming years

Next Generation Sequencing (NGS) Market By Application, Estimates and Forecast, 2014-2023 ($Million)
• Oncology
• Clinical Investigation
• Idiopathic Diseases
• Inherited Diseases
• Infectious Diseases
• Non-Communicable / Other Diseases
• Reproductive Health
• NIPT
• PGT
• Newborn/Genetic Screening
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Agrigenomics & Forensics
• Consumer Genomics

Next Generation Sequencing (NGS) Market By Technology, Estimates and Forecast, 2014-2023 ($Million)
• Targeted Sequencing Analysis
• DNA Based Targeted Sequencing Analysis
• RNA Based Targeted Sequencing Analysis
• Whole Genome Sequencing
• Whole Exome Sequencing

Next Generation Sequencing (NGS) Market By Work-flow, Estimates and Forecast, 2014-2023 ($Million)
• Pre-sequencing
• NGS Library Preparation Kits
• NGS Semi-Automated Library Preparation
• NGS Automated Library Preparation
• Clonal Amplification
• Sequencing
• Data Analysis
• Primary Data Analysis
• Secondary Data Analysis
• Tertiary Data Analysis

Next Generation Sequencing (NGS) Market By End User, Estimates and Forecast, 2014-2023 ($Million)
• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

Request Sample Report Copy Here @ www.crystalmarketresearch.com/report-sample/HC02601

Application Outlook and Trend Analysis:
Application-wise NGS technology has profitable approaches in preimplantation and prenatal genetic screening, developmental oncology, HLA typing/immune system monitoring, epidemiology & drug development, metagenomics, agrigenomics & forensics, clinical investigation, and consumer genomics. Oncology is expected to demonstrate profitable growth in the approaching years owing to the speedily developing of sequencing capabilities that facilitate directed sequence determination of an amount of cancer genes that allow oncologists to acquire genetic data exist in few of the less available dense gene clusters concerning cancer tumors and cells.

Organization Outlook and Trend Analysis:
Usage of these solutions in R&D projects that are executed in the research centers and universities are prenominal for the leading share due to the existence of a huge amount of R&D projects. On-site bioinformatics courses provision which includes the workshops on the actual implementation of data analysis and NGS are also anticipated to fuel revenue produced via academic research in the approaching years. Rising NGS-based smaller scale platforms’ adoption for medical diagnostics is also a major end market projected to fuel demand during the future.

Regional Overview:
In 2015, North American regional NGS market reported for the leading share. This huge share can be reported for the existence of an improved technological medical framework, rising adoption of declining in the price of sequencing for each base pair, and elevated R&D funding for proteomic and genomic sequence determination for research of biomarkers. Also, most of the respondents for clinical & academic use are situated in the UK, U.S., and Germany due to the existence of numerous universities that present courses for molecular biology in the region thus affecting the expansion of NGS industry in European and North American regional market. Asia Pacific region is anticipated to grow at the leading rate with a compound annual growth rate of around 18% over the forecast years due to escalating investment for escalating healthcare awareness levels of the regional population, development of healthcare, and escalating residual and per capita income levels.

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
North America (U.S, Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
Rest of the World (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates, Others)

Reasons to buy a Exclusive report?

An extensive research study on the Global Next Generation Sequencing market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Next Generation Sequencing market.
We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.
The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.

Read More Premium News of RELEASEWIRENEWS @ www.releasewire.com/press-releases/atrial-fibrillation-gl...

Major TOC of Next Generation Sequencing Market:

Chapter1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
…
Chapter2. Executive Summary
2.1. Key Highlights
…
Chapter3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growth of companion diagnostics and personalized medicine
3.2.1.2. Expansion of technological advancements in cloud computing and data integration
3.2.1.3. Increasing clinical prospect for NGS technology
3.2.2. Restraints
3.2.2.1. Lack of computational efficiency for data management
3.2.3. Opportunities
3.2.3.1. Technological advancement in cancer diagnostic process
…
Chapter4. Next Generation Sequencing (NGS) Market, By Application
4.1. Introduction
4.2. Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share By Application (2014-2017)
4.2.1. Global Next Generation Sequencing (NGS) Sales and Sales Share By Application (2014-2017)
4.2.2. Global Next Generation Sequencing (NGS) Revenue and Revenue Share By Application (2014-2017)
4.3. Next Generation Sequencing (NGS) Market Assessment and Forecast, By Application, 2014-2023
4.4. Oncology
4.4.1.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5. Clinical Investigation
4.5.1. Market Assessment and Forecast, By Type, 2014-2023 ($Million)
4.5.2. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.3. Idiopathic Diseases
4.5.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.4. Inherited Diseases
…CONTINUED FOR TOC